Global Anti-GFP Nanobody Supply, Demand and Key Producers, 2026-2032
The global Anti-GFP Nanobody market size is expected to reach $ 76.28 million by 2032, rising at a market growth of 8.4% CAGR during the forecast period (2026-2032).
Anti-GFP Nanobody refers to a small recombinant single-domain antibody, usually a camelid-derived VHH or sdAb, that specifically binds green fluorescent protein (GFP) and common GFP derivatives. It is mainly used as a research reagent for GFP-tagged protein capture, immunoprecipitation, co-immunoprecipitation, affinity purification, pull-down, ChIP, RIP, fluorescence signal enhancement, immunofluorescence, super-resolution imaging and live-cell or fixed-cell labeling. In this report, the market mainly includes anti-GFP VHH binding proteins, anti-GFP nanobody agarose beads, anti-GFP nanobody magnetic beads, GFP-Trap-type affinity reagents, GFP-Booster-type fluorescent nanobody probes, anti-GFP nanobody affinity gel and customized anti-GFP nanobody conjugates. The 2025 benchmark ASP is US$250 / unit, sales volume is 170.00k units, and average gross margin is 72%. The upstream industry chain includes GFP antigen, alpaca / llama immunization resources, VHH libraries, phage display platforms, recombinant expression systems, E. coli / mammalian expression media, affinity purification resins, fluorescent dyes, biotin, HRP, agarose beads, magnetic beads, linkers, buffers and stabilizers. The midstream includes nanobody discovery, sequence screening, recombinant expression, purification, conjugation, bead coupling, affinity testing, specificity validation, IP / Co-IP validation, imaging validation, lyophilization or liquid formulation, packaging and quality control. The downstream includes universities, life-science research institutes, biotechnology companies, pharmaceutical R&D labs, proteomics laboratories, imaging core facilities, cell biology labs, antibody reagent distributors and contract research organizations.
Anti-GFP Nanobody is a small but high-value life-science reagent segment. GFP remains one of the most widely used protein tags and fluorescent reporters in molecular biology, cell biology, live-cell imaging and protein interaction studies. Compared with conventional anti-GFP IgG antibodies, anti-GFP nanobodies are much smaller, recombinant, stable and easier to conjugate to beads, dyes, enzymes or other functional groups. This makes them especially attractive for GFP-fusion protein pull-down, Co-IP, proteomics, super-resolution microscopy and signal amplification. Demand is driven by continued use of GFP-tagged cell lines, CRISPR knock-in fluorescent tags, live-cell imaging, protein interaction mapping, IP-MS workflows, high-resolution microscopy and faster magnetic bead-based sample preparation. Market growth is also supported by premium formatted products such as GFP-Trap beads, GFP-Booster fluorescent probes, affinity gels and ready-to-use IP kits. However, the market is constrained by its niche research-only nature, competition from conventional anti-GFP antibodies, availability of homemade GFP nanobody beads, academic protocols, price sensitivity in university labs and substitution by other epitope tags such as FLAG, HA, Myc, His, HaloTag and SNAP-tag. Future competition will focus on higher binding capacity beads, lower nonspecific background, broader recognition of GFP variants, brighter dye conjugates, super-resolution imaging compatibility, automation-ready magnetic formats, multiplex fluorescent nanobodies and custom conjugation services.
This report studies the global Anti-GFP Nanobody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-GFP Nanobody and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-GFP Nanobody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-GFP Nanobody total production and demand, 2021-2032, (K Units)
Global Anti-GFP Nanobody total production value, 2021-2032, (USD Million)
Global Anti-GFP Nanobody production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Anti-GFP Nanobody consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Anti-GFP Nanobody domestic production, consumption, key domestic manufacturers and share
Global Anti-GFP Nanobody production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Anti-GFP Nanobody production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Anti-GFP Nanobody production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Anti-GFP Nanobody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Proteintech / ChromoTek, Proteintech / ChromoTek GFP-Booster, NanoTag Biotechnologies, NanoTag FluoTag-X4 anti-GFP, BioLegend, ABclonal Agarose Beads, Yeasen Biotechnology, AntibodySystem, Antibodies.com, MBL Life Science, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-GFP Nanobody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Anti-GFP Nanobody Market, By Region:
1. How big is the global Anti-GFP Nanobody market?
2. What is the demand of the global Anti-GFP Nanobody market?
3. What is the year over year growth of the global Anti-GFP Nanobody market?
4. What is the production and production value of the global Anti-GFP Nanobody market?
5. Who are the key producers in the global Anti-GFP Nanobody market?
6. What are the growth factors driving the market demand?
Anti-GFP Nanobody refers to a small recombinant single-domain antibody, usually a camelid-derived VHH or sdAb, that specifically binds green fluorescent protein (GFP) and common GFP derivatives. It is mainly used as a research reagent for GFP-tagged protein capture, immunoprecipitation, co-immunoprecipitation, affinity purification, pull-down, ChIP, RIP, fluorescence signal enhancement, immunofluorescence, super-resolution imaging and live-cell or fixed-cell labeling. In this report, the market mainly includes anti-GFP VHH binding proteins, anti-GFP nanobody agarose beads, anti-GFP nanobody magnetic beads, GFP-Trap-type affinity reagents, GFP-Booster-type fluorescent nanobody probes, anti-GFP nanobody affinity gel and customized anti-GFP nanobody conjugates. The 2025 benchmark ASP is US$250 / unit, sales volume is 170.00k units, and average gross margin is 72%. The upstream industry chain includes GFP antigen, alpaca / llama immunization resources, VHH libraries, phage display platforms, recombinant expression systems, E. coli / mammalian expression media, affinity purification resins, fluorescent dyes, biotin, HRP, agarose beads, magnetic beads, linkers, buffers and stabilizers. The midstream includes nanobody discovery, sequence screening, recombinant expression, purification, conjugation, bead coupling, affinity testing, specificity validation, IP / Co-IP validation, imaging validation, lyophilization or liquid formulation, packaging and quality control. The downstream includes universities, life-science research institutes, biotechnology companies, pharmaceutical R&D labs, proteomics laboratories, imaging core facilities, cell biology labs, antibody reagent distributors and contract research organizations.
Anti-GFP Nanobody is a small but high-value life-science reagent segment. GFP remains one of the most widely used protein tags and fluorescent reporters in molecular biology, cell biology, live-cell imaging and protein interaction studies. Compared with conventional anti-GFP IgG antibodies, anti-GFP nanobodies are much smaller, recombinant, stable and easier to conjugate to beads, dyes, enzymes or other functional groups. This makes them especially attractive for GFP-fusion protein pull-down, Co-IP, proteomics, super-resolution microscopy and signal amplification. Demand is driven by continued use of GFP-tagged cell lines, CRISPR knock-in fluorescent tags, live-cell imaging, protein interaction mapping, IP-MS workflows, high-resolution microscopy and faster magnetic bead-based sample preparation. Market growth is also supported by premium formatted products such as GFP-Trap beads, GFP-Booster fluorescent probes, affinity gels and ready-to-use IP kits. However, the market is constrained by its niche research-only nature, competition from conventional anti-GFP antibodies, availability of homemade GFP nanobody beads, academic protocols, price sensitivity in university labs and substitution by other epitope tags such as FLAG, HA, Myc, His, HaloTag and SNAP-tag. Future competition will focus on higher binding capacity beads, lower nonspecific background, broader recognition of GFP variants, brighter dye conjugates, super-resolution imaging compatibility, automation-ready magnetic formats, multiplex fluorescent nanobodies and custom conjugation services.
This report studies the global Anti-GFP Nanobody production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Anti-GFP Nanobody and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-GFP Nanobody that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Anti-GFP Nanobody total production and demand, 2021-2032, (K Units)
Global Anti-GFP Nanobody total production value, 2021-2032, (USD Million)
Global Anti-GFP Nanobody production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Anti-GFP Nanobody consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Anti-GFP Nanobody domestic production, consumption, key domestic manufacturers and share
Global Anti-GFP Nanobody production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Anti-GFP Nanobody production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Anti-GFP Nanobody production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Anti-GFP Nanobody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Proteintech / ChromoTek, Proteintech / ChromoTek GFP-Booster, NanoTag Biotechnologies, NanoTag FluoTag-X4 anti-GFP, BioLegend, ABclonal Agarose Beads, Yeasen Biotechnology, AntibodySystem, Antibodies.com, MBL Life Science, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-GFP Nanobody market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Anti-GFP Nanobody Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monovalent Nanobodies
- Bivalent Nanobodies
- Bispecific Nanobodies
- Multivalent Nanobodies
- Fused Nanobodies
- VHH Binding Protein
- Affinity Gel / Resin
- Magnetic Bead Reagent
- Ready-to-Use IP Kit
- Biotin-Conjugated Type
- Fluorophore-Conjugated Type
- HRP-Conjugated Type
- Bead-Coupled Type
- University Laboratory
- Research Institute
- Biotechnology Company
- Pharmaceutical R&D Lab
- Proteintech / ChromoTek
- Proteintech / ChromoTek GFP-Booster
- NanoTag Biotechnologies
- NanoTag FluoTag-X4 anti-GFP
- BioLegend
- ABclonal Agarose Beads
- Yeasen Biotechnology
- AntibodySystem
- Antibodies.com
- MBL Life Science
- Cosmo Bio
- Bulldog Bio
- System Biosciences
- Sino Biological
- CUSABIO / Wuhan Huamei Biotech
- MSE Supplies
- KTSM Life Science
1. How big is the global Anti-GFP Nanobody market?
2. What is the demand of the global Anti-GFP Nanobody market?
3. What is the year over year growth of the global Anti-GFP Nanobody market?
4. What is the production and production value of the global Anti-GFP Nanobody market?
5. Who are the key producers in the global Anti-GFP Nanobody market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Anti-GFP Nanobody Introduction
1.2 World Anti-GFP Nanobody Supply & Forecast
1.2.1 World Anti-GFP Nanobody Production Value (2021 & 2025 & 2032)
1.2.2 World Anti-GFP Nanobody Production (2021-2032)
1.2.3 World Anti-GFP Nanobody Pricing Trends (2021-2032)
1.3 World Anti-GFP Nanobody Production by Region (Based on Production Site)
1.3.1 World Anti-GFP Nanobody Production Value by Region (2021-2032)
1.3.2 World Anti-GFP Nanobody Production by Region (2021-2032)
1.3.3 World Anti-GFP Nanobody Average Price by Region (2021-2032)
1.3.4 North America Anti-GFP Nanobody Production (2021-2032)
1.3.5 Europe Anti-GFP Nanobody Production (2021-2032)
1.3.6 China Anti-GFP Nanobody Production (2021-2032)
1.3.7 Japan Anti-GFP Nanobody Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-GFP Nanobody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-GFP Nanobody Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-GFP Nanobody Demand (2021-2032)
2.2 World Anti-GFP Nanobody Consumption by Region
2.2.1 World Anti-GFP Nanobody Consumption by Region (2021-2026)
2.2.2 World Anti-GFP Nanobody Consumption Forecast by Region (2027-2032)
2.3 United States Anti-GFP Nanobody Consumption (2021-2032)
2.4 China Anti-GFP Nanobody Consumption (2021-2032)
2.5 Europe Anti-GFP Nanobody Consumption (2021-2032)
2.6 Japan Anti-GFP Nanobody Consumption (2021-2032)
2.7 South Korea Anti-GFP Nanobody Consumption (2021-2032)
2.8 ASEAN Anti-GFP Nanobody Consumption (2021-2032)
2.9 India Anti-GFP Nanobody Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-GFP Nanobody Production Value by Manufacturer (2021-2026)
3.2 World Anti-GFP Nanobody Production by Manufacturer (2021-2026)
3.3 World Anti-GFP Nanobody Average Price by Manufacturer (2021-2026)
3.4 Anti-GFP Nanobody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-GFP Nanobody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-GFP Nanobody in 2025
3.5.3 Global Concentration Ratios (CR8) for Anti-GFP Nanobody in 2025
3.6 Anti-GFP Nanobody Market: Overall Company Footprint Analysis
3.6.1 Anti-GFP Nanobody Market: Region Footprint
3.6.2 Anti-GFP Nanobody Market: Company Product Type Footprint
3.6.3 Anti-GFP Nanobody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-GFP Nanobody Production Value Comparison
4.1.1 United States VS China: Anti-GFP Nanobody Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Anti-GFP Nanobody Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Anti-GFP Nanobody Production Comparison
4.2.1 United States VS China: Anti-GFP Nanobody Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Anti-GFP Nanobody Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Anti-GFP Nanobody Consumption Comparison
4.3.1 United States VS China: Anti-GFP Nanobody Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Anti-GFP Nanobody Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Anti-GFP Nanobody Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-GFP Nanobody Production Value (2021-2026)
4.4.3 United States Based Manufacturers Anti-GFP Nanobody Production (2021-2026)
4.5 China Based Anti-GFP Nanobody Manufacturers and Market Share
4.5.1 China Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-GFP Nanobody Production Value (2021-2026)
4.5.3 China Based Manufacturers Anti-GFP Nanobody Production (2021-2026)
4.6 Rest of World Based Anti-GFP Nanobody Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-GFP Nanobody Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Anti-GFP Nanobody Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-GFP Nanobody Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monovalent Nanobodies
5.2.2 Bivalent Nanobodies
5.2.3 Bispecific Nanobodies
5.2.4 Multivalent Nanobodies
5.2.5 Fused Nanobodies
5.3 Market Segment by Type
5.3.1 World Anti-GFP Nanobody Production by Type (2021-2032)
5.3.2 World Anti-GFP Nanobody Production Value by Type (2021-2032)
5.3.3 World Anti-GFP Nanobody Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY REAGENT FORMAT
6.1 World Anti-GFP Nanobody Market Size Overview by Reagent Format: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Reagent Format
6.2.1 VHH Binding Protein
6.2.2 Affinity Gel / Resin
6.2.3 Magnetic Bead Reagent
6.2.4 Ready-to-Use IP Kit
6.3 Market Segment by Reagent Format
6.3.1 World Anti-GFP Nanobody Production by Reagent Format (2021-2032)
6.3.2 World Anti-GFP Nanobody Production Value by Reagent Format (2021-2032)
6.3.3 World Anti-GFP Nanobody Average Price by Reagent Format (2021-2032)
7 MARKET ANALYSIS BY CONJUGATION TYPE
7.1 World Anti-GFP Nanobody Market Size Overview by Conjugation Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Conjugation Type
7.2.1 Biotin-Conjugated Type
7.2.2 Fluorophore-Conjugated Type
7.2.3 HRP-Conjugated Type
7.2.4 Bead-Coupled Type
7.3 Market Segment by Conjugation Type
7.3.1 World Anti-GFP Nanobody Production by Conjugation Type (2021-2032)
7.3.2 World Anti-GFP Nanobody Production Value by Conjugation Type (2021-2032)
7.3.3 World Anti-GFP Nanobody Average Price by Conjugation Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Anti-GFP Nanobody Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 University Laboratory
8.2.2 Research Institute
8.2.3 Biotechnology Company
8.2.4 Pharmaceutical R&D Lab
8.3 Market Segment by Application
8.3.1 World Anti-GFP Nanobody Production by Application (2021-2032)
8.3.2 World Anti-GFP Nanobody Production Value by Application (2021-2032)
8.3.3 World Anti-GFP Nanobody Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Proteintech / ChromoTek
9.1.1 Proteintech / ChromoTek Details
9.1.2 Proteintech / ChromoTek Major Business
9.1.3 Proteintech / ChromoTek Anti-GFP Nanobody Product and Services
9.1.4 Proteintech / ChromoTek Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Proteintech / ChromoTek Recent Developments/Updates
9.1.6 Proteintech / ChromoTek Competitive Strengths & Weaknesses
9.2 Proteintech / ChromoTek GFP-Booster
9.2.1 Proteintech / ChromoTek GFP-Booster Details
9.2.2 Proteintech / ChromoTek GFP-Booster Major Business
9.2.3 Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Product and Services
9.2.4 Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Proteintech / ChromoTek GFP-Booster Recent Developments/Updates
9.2.6 Proteintech / ChromoTek GFP-Booster Competitive Strengths & Weaknesses
9.3 NanoTag Biotechnologies
9.3.1 NanoTag Biotechnologies Details
9.3.2 NanoTag Biotechnologies Major Business
9.3.3 NanoTag Biotechnologies Anti-GFP Nanobody Product and Services
9.3.4 NanoTag Biotechnologies Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 NanoTag Biotechnologies Recent Developments/Updates
9.3.6 NanoTag Biotechnologies Competitive Strengths & Weaknesses
9.4 NanoTag FluoTag-X4 anti-GFP
9.4.1 NanoTag FluoTag-X4 anti-GFP Details
9.4.2 NanoTag FluoTag-X4 anti-GFP Major Business
9.4.3 NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Product and Services
9.4.4 NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 NanoTag FluoTag-X4 anti-GFP Recent Developments/Updates
9.4.6 NanoTag FluoTag-X4 anti-GFP Competitive Strengths & Weaknesses
9.5 BioLegend
9.5.1 BioLegend Details
9.5.2 BioLegend Major Business
9.5.3 BioLegend Anti-GFP Nanobody Product and Services
9.5.4 BioLegend Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 BioLegend Recent Developments/Updates
9.5.6 BioLegend Competitive Strengths & Weaknesses
9.6 ABclonal Agarose Beads
9.6.1 ABclonal Agarose Beads Details
9.6.2 ABclonal Agarose Beads Major Business
9.6.3 ABclonal Agarose Beads Anti-GFP Nanobody Product and Services
9.6.4 ABclonal Agarose Beads Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 ABclonal Agarose Beads Recent Developments/Updates
9.6.6 ABclonal Agarose Beads Competitive Strengths & Weaknesses
9.7 Yeasen Biotechnology
9.7.1 Yeasen Biotechnology Details
9.7.2 Yeasen Biotechnology Major Business
9.7.3 Yeasen Biotechnology Anti-GFP Nanobody Product and Services
9.7.4 Yeasen Biotechnology Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Yeasen Biotechnology Recent Developments/Updates
9.7.6 Yeasen Biotechnology Competitive Strengths & Weaknesses
9.8 AntibodySystem
9.8.1 AntibodySystem Details
9.8.2 AntibodySystem Major Business
9.8.3 AntibodySystem Anti-GFP Nanobody Product and Services
9.8.4 AntibodySystem Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 AntibodySystem Recent Developments/Updates
9.8.6 AntibodySystem Competitive Strengths & Weaknesses
9.9 Antibodies.com
9.9.1 Antibodies.com Details
9.9.2 Antibodies.com Major Business
9.9.3 Antibodies.com Anti-GFP Nanobody Product and Services
9.9.4 Antibodies.com Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Antibodies.com Recent Developments/Updates
9.9.6 Antibodies.com Competitive Strengths & Weaknesses
9.10 MBL Life Science
9.10.1 MBL Life Science Details
9.10.2 MBL Life Science Major Business
9.10.3 MBL Life Science Anti-GFP Nanobody Product and Services
9.10.4 MBL Life Science Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 MBL Life Science Recent Developments/Updates
9.10.6 MBL Life Science Competitive Strengths & Weaknesses
9.11 Cosmo Bio
9.11.1 Cosmo Bio Details
9.11.2 Cosmo Bio Major Business
9.11.3 Cosmo Bio Anti-GFP Nanobody Product and Services
9.11.4 Cosmo Bio Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Cosmo Bio Recent Developments/Updates
9.11.6 Cosmo Bio Competitive Strengths & Weaknesses
9.12 Bulldog Bio
9.12.1 Bulldog Bio Details
9.12.2 Bulldog Bio Major Business
9.12.3 Bulldog Bio Anti-GFP Nanobody Product and Services
9.12.4 Bulldog Bio Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Bulldog Bio Recent Developments/Updates
9.12.6 Bulldog Bio Competitive Strengths & Weaknesses
9.13 System Biosciences
9.13.1 System Biosciences Details
9.13.2 System Biosciences Major Business
9.13.3 System Biosciences Anti-GFP Nanobody Product and Services
9.13.4 System Biosciences Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 System Biosciences Recent Developments/Updates
9.13.6 System Biosciences Competitive Strengths & Weaknesses
9.14 Sino Biological
9.14.1 Sino Biological Details
9.14.2 Sino Biological Major Business
9.14.3 Sino Biological Anti-GFP Nanobody Product and Services
9.14.4 Sino Biological Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Sino Biological Recent Developments/Updates
9.14.6 Sino Biological Competitive Strengths & Weaknesses
9.15 CUSABIO / Wuhan Huamei Biotech
9.15.1 CUSABIO / Wuhan Huamei Biotech Details
9.15.2 CUSABIO / Wuhan Huamei Biotech Major Business
9.15.3 CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Product and Services
9.15.4 CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 CUSABIO / Wuhan Huamei Biotech Recent Developments/Updates
9.15.6 CUSABIO / Wuhan Huamei Biotech Competitive Strengths & Weaknesses
9.16 MSE Supplies
9.16.1 MSE Supplies Details
9.16.2 MSE Supplies Major Business
9.16.3 MSE Supplies Anti-GFP Nanobody Product and Services
9.16.4 MSE Supplies Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 MSE Supplies Recent Developments/Updates
9.16.6 MSE Supplies Competitive Strengths & Weaknesses
9.17 KTSM Life Science
9.17.1 KTSM Life Science Details
9.17.2 KTSM Life Science Major Business
9.17.3 KTSM Life Science Anti-GFP Nanobody Product and Services
9.17.4 KTSM Life Science Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 KTSM Life Science Recent Developments/Updates
9.17.6 KTSM Life Science Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Anti-GFP Nanobody Industry Chain
10.2 Anti-GFP Nanobody Upstream Analysis
10.2.1 Anti-GFP Nanobody Core Raw Materials
10.2.2 Main Manufacturers of Anti-GFP Nanobody Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Anti-GFP Nanobody Production Mode
10.6 Anti-GFP Nanobody Procurement Model
10.7 Anti-GFP Nanobody Industry Sales Model and Sales Channels
10.7.1 Anti-GFP Nanobody Sales Model
10.7.2 Anti-GFP Nanobody Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Anti-GFP Nanobody Introduction
1.2 World Anti-GFP Nanobody Supply & Forecast
1.2.1 World Anti-GFP Nanobody Production Value (2021 & 2025 & 2032)
1.2.2 World Anti-GFP Nanobody Production (2021-2032)
1.2.3 World Anti-GFP Nanobody Pricing Trends (2021-2032)
1.3 World Anti-GFP Nanobody Production by Region (Based on Production Site)
1.3.1 World Anti-GFP Nanobody Production Value by Region (2021-2032)
1.3.2 World Anti-GFP Nanobody Production by Region (2021-2032)
1.3.3 World Anti-GFP Nanobody Average Price by Region (2021-2032)
1.3.4 North America Anti-GFP Nanobody Production (2021-2032)
1.3.5 Europe Anti-GFP Nanobody Production (2021-2032)
1.3.6 China Anti-GFP Nanobody Production (2021-2032)
1.3.7 Japan Anti-GFP Nanobody Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Anti-GFP Nanobody Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Anti-GFP Nanobody Major Market Trends
2 DEMAND SUMMARY
2.1 World Anti-GFP Nanobody Demand (2021-2032)
2.2 World Anti-GFP Nanobody Consumption by Region
2.2.1 World Anti-GFP Nanobody Consumption by Region (2021-2026)
2.2.2 World Anti-GFP Nanobody Consumption Forecast by Region (2027-2032)
2.3 United States Anti-GFP Nanobody Consumption (2021-2032)
2.4 China Anti-GFP Nanobody Consumption (2021-2032)
2.5 Europe Anti-GFP Nanobody Consumption (2021-2032)
2.6 Japan Anti-GFP Nanobody Consumption (2021-2032)
2.7 South Korea Anti-GFP Nanobody Consumption (2021-2032)
2.8 ASEAN Anti-GFP Nanobody Consumption (2021-2032)
2.9 India Anti-GFP Nanobody Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Anti-GFP Nanobody Production Value by Manufacturer (2021-2026)
3.2 World Anti-GFP Nanobody Production by Manufacturer (2021-2026)
3.3 World Anti-GFP Nanobody Average Price by Manufacturer (2021-2026)
3.4 Anti-GFP Nanobody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Anti-GFP Nanobody Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Anti-GFP Nanobody in 2025
3.5.3 Global Concentration Ratios (CR8) for Anti-GFP Nanobody in 2025
3.6 Anti-GFP Nanobody Market: Overall Company Footprint Analysis
3.6.1 Anti-GFP Nanobody Market: Region Footprint
3.6.2 Anti-GFP Nanobody Market: Company Product Type Footprint
3.6.3 Anti-GFP Nanobody Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Anti-GFP Nanobody Production Value Comparison
4.1.1 United States VS China: Anti-GFP Nanobody Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Anti-GFP Nanobody Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Anti-GFP Nanobody Production Comparison
4.2.1 United States VS China: Anti-GFP Nanobody Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Anti-GFP Nanobody Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Anti-GFP Nanobody Consumption Comparison
4.3.1 United States VS China: Anti-GFP Nanobody Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Anti-GFP Nanobody Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Anti-GFP Nanobody Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Anti-GFP Nanobody Production Value (2021-2026)
4.4.3 United States Based Manufacturers Anti-GFP Nanobody Production (2021-2026)
4.5 China Based Anti-GFP Nanobody Manufacturers and Market Share
4.5.1 China Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Anti-GFP Nanobody Production Value (2021-2026)
4.5.3 China Based Manufacturers Anti-GFP Nanobody Production (2021-2026)
4.6 Rest of World Based Anti-GFP Nanobody Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Anti-GFP Nanobody Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Anti-GFP Nanobody Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Anti-GFP Nanobody Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monovalent Nanobodies
5.2.2 Bivalent Nanobodies
5.2.3 Bispecific Nanobodies
5.2.4 Multivalent Nanobodies
5.2.5 Fused Nanobodies
5.3 Market Segment by Type
5.3.1 World Anti-GFP Nanobody Production by Type (2021-2032)
5.3.2 World Anti-GFP Nanobody Production Value by Type (2021-2032)
5.3.3 World Anti-GFP Nanobody Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY REAGENT FORMAT
6.1 World Anti-GFP Nanobody Market Size Overview by Reagent Format: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Reagent Format
6.2.1 VHH Binding Protein
6.2.2 Affinity Gel / Resin
6.2.3 Magnetic Bead Reagent
6.2.4 Ready-to-Use IP Kit
6.3 Market Segment by Reagent Format
6.3.1 World Anti-GFP Nanobody Production by Reagent Format (2021-2032)
6.3.2 World Anti-GFP Nanobody Production Value by Reagent Format (2021-2032)
6.3.3 World Anti-GFP Nanobody Average Price by Reagent Format (2021-2032)
7 MARKET ANALYSIS BY CONJUGATION TYPE
7.1 World Anti-GFP Nanobody Market Size Overview by Conjugation Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Conjugation Type
7.2.1 Biotin-Conjugated Type
7.2.2 Fluorophore-Conjugated Type
7.2.3 HRP-Conjugated Type
7.2.4 Bead-Coupled Type
7.3 Market Segment by Conjugation Type
7.3.1 World Anti-GFP Nanobody Production by Conjugation Type (2021-2032)
7.3.2 World Anti-GFP Nanobody Production Value by Conjugation Type (2021-2032)
7.3.3 World Anti-GFP Nanobody Average Price by Conjugation Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Anti-GFP Nanobody Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 University Laboratory
8.2.2 Research Institute
8.2.3 Biotechnology Company
8.2.4 Pharmaceutical R&D Lab
8.3 Market Segment by Application
8.3.1 World Anti-GFP Nanobody Production by Application (2021-2032)
8.3.2 World Anti-GFP Nanobody Production Value by Application (2021-2032)
8.3.3 World Anti-GFP Nanobody Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Proteintech / ChromoTek
9.1.1 Proteintech / ChromoTek Details
9.1.2 Proteintech / ChromoTek Major Business
9.1.3 Proteintech / ChromoTek Anti-GFP Nanobody Product and Services
9.1.4 Proteintech / ChromoTek Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Proteintech / ChromoTek Recent Developments/Updates
9.1.6 Proteintech / ChromoTek Competitive Strengths & Weaknesses
9.2 Proteintech / ChromoTek GFP-Booster
9.2.1 Proteintech / ChromoTek GFP-Booster Details
9.2.2 Proteintech / ChromoTek GFP-Booster Major Business
9.2.3 Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Product and Services
9.2.4 Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Proteintech / ChromoTek GFP-Booster Recent Developments/Updates
9.2.6 Proteintech / ChromoTek GFP-Booster Competitive Strengths & Weaknesses
9.3 NanoTag Biotechnologies
9.3.1 NanoTag Biotechnologies Details
9.3.2 NanoTag Biotechnologies Major Business
9.3.3 NanoTag Biotechnologies Anti-GFP Nanobody Product and Services
9.3.4 NanoTag Biotechnologies Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 NanoTag Biotechnologies Recent Developments/Updates
9.3.6 NanoTag Biotechnologies Competitive Strengths & Weaknesses
9.4 NanoTag FluoTag-X4 anti-GFP
9.4.1 NanoTag FluoTag-X4 anti-GFP Details
9.4.2 NanoTag FluoTag-X4 anti-GFP Major Business
9.4.3 NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Product and Services
9.4.4 NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 NanoTag FluoTag-X4 anti-GFP Recent Developments/Updates
9.4.6 NanoTag FluoTag-X4 anti-GFP Competitive Strengths & Weaknesses
9.5 BioLegend
9.5.1 BioLegend Details
9.5.2 BioLegend Major Business
9.5.3 BioLegend Anti-GFP Nanobody Product and Services
9.5.4 BioLegend Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 BioLegend Recent Developments/Updates
9.5.6 BioLegend Competitive Strengths & Weaknesses
9.6 ABclonal Agarose Beads
9.6.1 ABclonal Agarose Beads Details
9.6.2 ABclonal Agarose Beads Major Business
9.6.3 ABclonal Agarose Beads Anti-GFP Nanobody Product and Services
9.6.4 ABclonal Agarose Beads Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 ABclonal Agarose Beads Recent Developments/Updates
9.6.6 ABclonal Agarose Beads Competitive Strengths & Weaknesses
9.7 Yeasen Biotechnology
9.7.1 Yeasen Biotechnology Details
9.7.2 Yeasen Biotechnology Major Business
9.7.3 Yeasen Biotechnology Anti-GFP Nanobody Product and Services
9.7.4 Yeasen Biotechnology Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Yeasen Biotechnology Recent Developments/Updates
9.7.6 Yeasen Biotechnology Competitive Strengths & Weaknesses
9.8 AntibodySystem
9.8.1 AntibodySystem Details
9.8.2 AntibodySystem Major Business
9.8.3 AntibodySystem Anti-GFP Nanobody Product and Services
9.8.4 AntibodySystem Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 AntibodySystem Recent Developments/Updates
9.8.6 AntibodySystem Competitive Strengths & Weaknesses
9.9 Antibodies.com
9.9.1 Antibodies.com Details
9.9.2 Antibodies.com Major Business
9.9.3 Antibodies.com Anti-GFP Nanobody Product and Services
9.9.4 Antibodies.com Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Antibodies.com Recent Developments/Updates
9.9.6 Antibodies.com Competitive Strengths & Weaknesses
9.10 MBL Life Science
9.10.1 MBL Life Science Details
9.10.2 MBL Life Science Major Business
9.10.3 MBL Life Science Anti-GFP Nanobody Product and Services
9.10.4 MBL Life Science Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 MBL Life Science Recent Developments/Updates
9.10.6 MBL Life Science Competitive Strengths & Weaknesses
9.11 Cosmo Bio
9.11.1 Cosmo Bio Details
9.11.2 Cosmo Bio Major Business
9.11.3 Cosmo Bio Anti-GFP Nanobody Product and Services
9.11.4 Cosmo Bio Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Cosmo Bio Recent Developments/Updates
9.11.6 Cosmo Bio Competitive Strengths & Weaknesses
9.12 Bulldog Bio
9.12.1 Bulldog Bio Details
9.12.2 Bulldog Bio Major Business
9.12.3 Bulldog Bio Anti-GFP Nanobody Product and Services
9.12.4 Bulldog Bio Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Bulldog Bio Recent Developments/Updates
9.12.6 Bulldog Bio Competitive Strengths & Weaknesses
9.13 System Biosciences
9.13.1 System Biosciences Details
9.13.2 System Biosciences Major Business
9.13.3 System Biosciences Anti-GFP Nanobody Product and Services
9.13.4 System Biosciences Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 System Biosciences Recent Developments/Updates
9.13.6 System Biosciences Competitive Strengths & Weaknesses
9.14 Sino Biological
9.14.1 Sino Biological Details
9.14.2 Sino Biological Major Business
9.14.3 Sino Biological Anti-GFP Nanobody Product and Services
9.14.4 Sino Biological Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Sino Biological Recent Developments/Updates
9.14.6 Sino Biological Competitive Strengths & Weaknesses
9.15 CUSABIO / Wuhan Huamei Biotech
9.15.1 CUSABIO / Wuhan Huamei Biotech Details
9.15.2 CUSABIO / Wuhan Huamei Biotech Major Business
9.15.3 CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Product and Services
9.15.4 CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 CUSABIO / Wuhan Huamei Biotech Recent Developments/Updates
9.15.6 CUSABIO / Wuhan Huamei Biotech Competitive Strengths & Weaknesses
9.16 MSE Supplies
9.16.1 MSE Supplies Details
9.16.2 MSE Supplies Major Business
9.16.3 MSE Supplies Anti-GFP Nanobody Product and Services
9.16.4 MSE Supplies Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 MSE Supplies Recent Developments/Updates
9.16.6 MSE Supplies Competitive Strengths & Weaknesses
9.17 KTSM Life Science
9.17.1 KTSM Life Science Details
9.17.2 KTSM Life Science Major Business
9.17.3 KTSM Life Science Anti-GFP Nanobody Product and Services
9.17.4 KTSM Life Science Anti-GFP Nanobody Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 KTSM Life Science Recent Developments/Updates
9.17.6 KTSM Life Science Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Anti-GFP Nanobody Industry Chain
10.2 Anti-GFP Nanobody Upstream Analysis
10.2.1 Anti-GFP Nanobody Core Raw Materials
10.2.2 Main Manufacturers of Anti-GFP Nanobody Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Anti-GFP Nanobody Production Mode
10.6 Anti-GFP Nanobody Procurement Model
10.7 Anti-GFP Nanobody Industry Sales Model and Sales Channels
10.7.1 Anti-GFP Nanobody Sales Model
10.7.2 Anti-GFP Nanobody Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Anti-GFP Nanobody Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Anti-GFP Nanobody Production Value by Region (2021-2026) & (USD Million)
Table 3. World Anti-GFP Nanobody Production Value by Region (2027-2032) & (USD Million)
Table 4. World Anti-GFP Nanobody Production Value Market Share by Region (2021-2026)
Table 5. World Anti-GFP Nanobody Production Value Market Share by Region (2027-2032)
Table 6. World Anti-GFP Nanobody Production by Region (2021-2026) & (K Units)
Table 7. World Anti-GFP Nanobody Production by Region (2027-2032) & (K Units)
Table 8. World Anti-GFP Nanobody Production Market Share by Region (2021-2026)
Table 9. World Anti-GFP Nanobody Production Market Share by Region (2027-2032)
Table 10. World Anti-GFP Nanobody Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Anti-GFP Nanobody Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Anti-GFP Nanobody Major Market Trends
Table 13. World Anti-GFP Nanobody Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Anti-GFP Nanobody Consumption by Region (2021-2026) & (K Units)
Table 15. World Anti-GFP Nanobody Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Anti-GFP Nanobody Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Anti-GFP Nanobody Producers in 2025
Table 18. World Anti-GFP Nanobody Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Anti-GFP Nanobody Producers in 2025
Table 20. World Anti-GFP Nanobody Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Anti-GFP Nanobody Company Evaluation Quadrant
Table 22. World Anti-GFP Nanobody Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Anti-GFP Nanobody Production Site of Key Manufacturer
Table 24. Anti-GFP Nanobody Market: Company Product Type Footprint
Table 25. Anti-GFP Nanobody Market: Company Product Application Footprint
Table 26. Anti-GFP Nanobody Competitive Factors
Table 27. Anti-GFP Nanobody New Entrant and Capacity Expansion Plans
Table 28. Anti-GFP Nanobody Mergers & Acquisitions Activity
Table 29. United States VS China Anti-GFP Nanobody Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Anti-GFP Nanobody Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Anti-GFP Nanobody Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-GFP Nanobody Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Anti-GFP Nanobody Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Anti-GFP Nanobody Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Anti-GFP Nanobody Production Market Share (2021-2026)
Table 37. China Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-GFP Nanobody Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Anti-GFP Nanobody Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Anti-GFP Nanobody Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Anti-GFP Nanobody Production Market Share (2021-2026)
Table 42. Rest of World Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Anti-GFP Nanobody Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-GFP Nanobody Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Anti-GFP Nanobody Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-GFP Nanobody Production Market Share (2021-2026)
Table 47. World Anti-GFP Nanobody Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Anti-GFP Nanobody Production by Type (2021-2026) & (K Units)
Table 49. World Anti-GFP Nanobody Production by Type (2027-2032) & (K Units)
Table 50. World Anti-GFP Nanobody Production Value by Type (2021-2026) & (USD Million)
Table 51. World Anti-GFP Nanobody Production Value by Type (2027-2032) & (USD Million)
Table 52. World Anti-GFP Nanobody Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Anti-GFP Nanobody Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Anti-GFP Nanobody Production Value by Reagent Format, (USD Million), 2021 & 2025 & 2032
Table 55. World Anti-GFP Nanobody Production by Reagent Format (2021-2026) & (K Units)
Table 56. World Anti-GFP Nanobody Production by Reagent Format (2027-2032) & (K Units)
Table 57. World Anti-GFP Nanobody Production Value by Reagent Format (2021-2026) & (USD Million)
Table 58. World Anti-GFP Nanobody Production Value by Reagent Format (2027-2032) & (USD Million)
Table 59. World Anti-GFP Nanobody Average Price by Reagent Format (2021-2026) & (US$/Unit)
Table 60. World Anti-GFP Nanobody Average Price by Reagent Format (2027-2032) & (US$/Unit)
Table 61. World Anti-GFP Nanobody Production Value by Conjugation Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Anti-GFP Nanobody Production by Conjugation Type (2021-2026) & (K Units)
Table 63. World Anti-GFP Nanobody Production by Conjugation Type (2027-2032) & (K Units)
Table 64. World Anti-GFP Nanobody Production Value by Conjugation Type (2021-2026) & (USD Million)
Table 65. World Anti-GFP Nanobody Production Value by Conjugation Type (2027-2032) & (USD Million)
Table 66. World Anti-GFP Nanobody Average Price by Conjugation Type (2021-2026) & (US$/Unit)
Table 67. World Anti-GFP Nanobody Average Price by Conjugation Type (2027-2032) & (US$/Unit)
Table 68. World Anti-GFP Nanobody Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Anti-GFP Nanobody Production by Application (2021-2026) & (K Units)
Table 70. World Anti-GFP Nanobody Production by Application (2027-2032) & (K Units)
Table 71. World Anti-GFP Nanobody Production Value by Application (2021-2026) & (USD Million)
Table 72. World Anti-GFP Nanobody Production Value by Application (2027-2032) & (USD Million)
Table 73. World Anti-GFP Nanobody Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Anti-GFP Nanobody Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Proteintech / ChromoTek Basic Information, Manufacturing Base and Competitors
Table 76. Proteintech / ChromoTek Major Business
Table 77. Proteintech / ChromoTek Anti-GFP Nanobody Product and Services
Table 78. Proteintech / ChromoTek Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Proteintech / ChromoTek Recent Developments/Updates
Table 80. Proteintech / ChromoTek Competitive Strengths & Weaknesses
Table 81. Proteintech / ChromoTek GFP-Booster Basic Information, Manufacturing Base and Competitors
Table 82. Proteintech / ChromoTek GFP-Booster Major Business
Table 83. Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Product and Services
Table 84. Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Proteintech / ChromoTek GFP-Booster Recent Developments/Updates
Table 86. Proteintech / ChromoTek GFP-Booster Competitive Strengths & Weaknesses
Table 87. NanoTag Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 88. NanoTag Biotechnologies Major Business
Table 89. NanoTag Biotechnologies Anti-GFP Nanobody Product and Services
Table 90. NanoTag Biotechnologies Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. NanoTag Biotechnologies Recent Developments/Updates
Table 92. NanoTag Biotechnologies Competitive Strengths & Weaknesses
Table 93. NanoTag FluoTag-X4 anti-GFP Basic Information, Manufacturing Base and Competitors
Table 94. NanoTag FluoTag-X4 anti-GFP Major Business
Table 95. NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Product and Services
Table 96. NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. NanoTag FluoTag-X4 anti-GFP Recent Developments/Updates
Table 98. NanoTag FluoTag-X4 anti-GFP Competitive Strengths & Weaknesses
Table 99. BioLegend Basic Information, Manufacturing Base and Competitors
Table 100. BioLegend Major Business
Table 101. BioLegend Anti-GFP Nanobody Product and Services
Table 102. BioLegend Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. BioLegend Recent Developments/Updates
Table 104. BioLegend Competitive Strengths & Weaknesses
Table 105. ABclonal Agarose Beads Basic Information, Manufacturing Base and Competitors
Table 106. ABclonal Agarose Beads Major Business
Table 107. ABclonal Agarose Beads Anti-GFP Nanobody Product and Services
Table 108. ABclonal Agarose Beads Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. ABclonal Agarose Beads Recent Developments/Updates
Table 110. ABclonal Agarose Beads Competitive Strengths & Weaknesses
Table 111. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 112. Yeasen Biotechnology Major Business
Table 113. Yeasen Biotechnology Anti-GFP Nanobody Product and Services
Table 114. Yeasen Biotechnology Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Yeasen Biotechnology Recent Developments/Updates
Table 116. Yeasen Biotechnology Competitive Strengths & Weaknesses
Table 117. AntibodySystem Basic Information, Manufacturing Base and Competitors
Table 118. AntibodySystem Major Business
Table 119. AntibodySystem Anti-GFP Nanobody Product and Services
Table 120. AntibodySystem Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. AntibodySystem Recent Developments/Updates
Table 122. AntibodySystem Competitive Strengths & Weaknesses
Table 123. Antibodies.com Basic Information, Manufacturing Base and Competitors
Table 124. Antibodies.com Major Business
Table 125. Antibodies.com Anti-GFP Nanobody Product and Services
Table 126. Antibodies.com Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Antibodies.com Recent Developments/Updates
Table 128. Antibodies.com Competitive Strengths & Weaknesses
Table 129. MBL Life Science Basic Information, Manufacturing Base and Competitors
Table 130. MBL Life Science Major Business
Table 131. MBL Life Science Anti-GFP Nanobody Product and Services
Table 132. MBL Life Science Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. MBL Life Science Recent Developments/Updates
Table 134. MBL Life Science Competitive Strengths & Weaknesses
Table 135. Cosmo Bio Basic Information, Manufacturing Base and Competitors
Table 136. Cosmo Bio Major Business
Table 137. Cosmo Bio Anti-GFP Nanobody Product and Services
Table 138. Cosmo Bio Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Cosmo Bio Recent Developments/Updates
Table 140. Cosmo Bio Competitive Strengths & Weaknesses
Table 141. Bulldog Bio Basic Information, Manufacturing Base and Competitors
Table 142. Bulldog Bio Major Business
Table 143. Bulldog Bio Anti-GFP Nanobody Product and Services
Table 144. Bulldog Bio Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Bulldog Bio Recent Developments/Updates
Table 146. Bulldog Bio Competitive Strengths & Weaknesses
Table 147. System Biosciences Basic Information, Manufacturing Base and Competitors
Table 148. System Biosciences Major Business
Table 149. System Biosciences Anti-GFP Nanobody Product and Services
Table 150. System Biosciences Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. System Biosciences Recent Developments/Updates
Table 152. System Biosciences Competitive Strengths & Weaknesses
Table 153. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 154. Sino Biological Major Business
Table 155. Sino Biological Anti-GFP Nanobody Product and Services
Table 156. Sino Biological Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Sino Biological Recent Developments/Updates
Table 158. Sino Biological Competitive Strengths & Weaknesses
Table 159. CUSABIO / Wuhan Huamei Biotech Basic Information, Manufacturing Base and Competitors
Table 160. CUSABIO / Wuhan Huamei Biotech Major Business
Table 161. CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Product and Services
Table 162. CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. CUSABIO / Wuhan Huamei Biotech Recent Developments/Updates
Table 164. CUSABIO / Wuhan Huamei Biotech Competitive Strengths & Weaknesses
Table 165. MSE Supplies Basic Information, Manufacturing Base and Competitors
Table 166. MSE Supplies Major Business
Table 167. MSE Supplies Anti-GFP Nanobody Product and Services
Table 168. MSE Supplies Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. MSE Supplies Recent Developments/Updates
Table 170. MSE Supplies Competitive Strengths & Weaknesses
Table 171. KTSM Life Science Basic Information, Manufacturing Base and Competitors
Table 172. KTSM Life Science Major Business
Table 173. KTSM Life Science Anti-GFP Nanobody Product and Services
Table 174. KTSM Life Science Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. KTSM Life Science Recent Developments/Updates
Table 176. KTSM Life Science Competitive Strengths & Weaknesses
Table 177. Global Key Players of Anti-GFP Nanobody Upstream (Raw Materials)
Table 178. Global Anti-GFP Nanobody Typical Customers
Table 179. Anti-GFP Nanobody Typical Distributors
Table 1. World Anti-GFP Nanobody Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Anti-GFP Nanobody Production Value by Region (2021-2026) & (USD Million)
Table 3. World Anti-GFP Nanobody Production Value by Region (2027-2032) & (USD Million)
Table 4. World Anti-GFP Nanobody Production Value Market Share by Region (2021-2026)
Table 5. World Anti-GFP Nanobody Production Value Market Share by Region (2027-2032)
Table 6. World Anti-GFP Nanobody Production by Region (2021-2026) & (K Units)
Table 7. World Anti-GFP Nanobody Production by Region (2027-2032) & (K Units)
Table 8. World Anti-GFP Nanobody Production Market Share by Region (2021-2026)
Table 9. World Anti-GFP Nanobody Production Market Share by Region (2027-2032)
Table 10. World Anti-GFP Nanobody Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Anti-GFP Nanobody Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Anti-GFP Nanobody Major Market Trends
Table 13. World Anti-GFP Nanobody Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Anti-GFP Nanobody Consumption by Region (2021-2026) & (K Units)
Table 15. World Anti-GFP Nanobody Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Anti-GFP Nanobody Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Anti-GFP Nanobody Producers in 2025
Table 18. World Anti-GFP Nanobody Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Anti-GFP Nanobody Producers in 2025
Table 20. World Anti-GFP Nanobody Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Anti-GFP Nanobody Company Evaluation Quadrant
Table 22. World Anti-GFP Nanobody Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Anti-GFP Nanobody Production Site of Key Manufacturer
Table 24. Anti-GFP Nanobody Market: Company Product Type Footprint
Table 25. Anti-GFP Nanobody Market: Company Product Application Footprint
Table 26. Anti-GFP Nanobody Competitive Factors
Table 27. Anti-GFP Nanobody New Entrant and Capacity Expansion Plans
Table 28. Anti-GFP Nanobody Mergers & Acquisitions Activity
Table 29. United States VS China Anti-GFP Nanobody Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Anti-GFP Nanobody Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Anti-GFP Nanobody Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-GFP Nanobody Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Anti-GFP Nanobody Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Anti-GFP Nanobody Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Anti-GFP Nanobody Production Market Share (2021-2026)
Table 37. China Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-GFP Nanobody Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Anti-GFP Nanobody Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Anti-GFP Nanobody Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Anti-GFP Nanobody Production Market Share (2021-2026)
Table 42. Rest of World Based Anti-GFP Nanobody Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Anti-GFP Nanobody Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-GFP Nanobody Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Anti-GFP Nanobody Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-GFP Nanobody Production Market Share (2021-2026)
Table 47. World Anti-GFP Nanobody Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Anti-GFP Nanobody Production by Type (2021-2026) & (K Units)
Table 49. World Anti-GFP Nanobody Production by Type (2027-2032) & (K Units)
Table 50. World Anti-GFP Nanobody Production Value by Type (2021-2026) & (USD Million)
Table 51. World Anti-GFP Nanobody Production Value by Type (2027-2032) & (USD Million)
Table 52. World Anti-GFP Nanobody Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Anti-GFP Nanobody Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Anti-GFP Nanobody Production Value by Reagent Format, (USD Million), 2021 & 2025 & 2032
Table 55. World Anti-GFP Nanobody Production by Reagent Format (2021-2026) & (K Units)
Table 56. World Anti-GFP Nanobody Production by Reagent Format (2027-2032) & (K Units)
Table 57. World Anti-GFP Nanobody Production Value by Reagent Format (2021-2026) & (USD Million)
Table 58. World Anti-GFP Nanobody Production Value by Reagent Format (2027-2032) & (USD Million)
Table 59. World Anti-GFP Nanobody Average Price by Reagent Format (2021-2026) & (US$/Unit)
Table 60. World Anti-GFP Nanobody Average Price by Reagent Format (2027-2032) & (US$/Unit)
Table 61. World Anti-GFP Nanobody Production Value by Conjugation Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Anti-GFP Nanobody Production by Conjugation Type (2021-2026) & (K Units)
Table 63. World Anti-GFP Nanobody Production by Conjugation Type (2027-2032) & (K Units)
Table 64. World Anti-GFP Nanobody Production Value by Conjugation Type (2021-2026) & (USD Million)
Table 65. World Anti-GFP Nanobody Production Value by Conjugation Type (2027-2032) & (USD Million)
Table 66. World Anti-GFP Nanobody Average Price by Conjugation Type (2021-2026) & (US$/Unit)
Table 67. World Anti-GFP Nanobody Average Price by Conjugation Type (2027-2032) & (US$/Unit)
Table 68. World Anti-GFP Nanobody Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Anti-GFP Nanobody Production by Application (2021-2026) & (K Units)
Table 70. World Anti-GFP Nanobody Production by Application (2027-2032) & (K Units)
Table 71. World Anti-GFP Nanobody Production Value by Application (2021-2026) & (USD Million)
Table 72. World Anti-GFP Nanobody Production Value by Application (2027-2032) & (USD Million)
Table 73. World Anti-GFP Nanobody Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Anti-GFP Nanobody Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Proteintech / ChromoTek Basic Information, Manufacturing Base and Competitors
Table 76. Proteintech / ChromoTek Major Business
Table 77. Proteintech / ChromoTek Anti-GFP Nanobody Product and Services
Table 78. Proteintech / ChromoTek Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Proteintech / ChromoTek Recent Developments/Updates
Table 80. Proteintech / ChromoTek Competitive Strengths & Weaknesses
Table 81. Proteintech / ChromoTek GFP-Booster Basic Information, Manufacturing Base and Competitors
Table 82. Proteintech / ChromoTek GFP-Booster Major Business
Table 83. Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Product and Services
Table 84. Proteintech / ChromoTek GFP-Booster Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Proteintech / ChromoTek GFP-Booster Recent Developments/Updates
Table 86. Proteintech / ChromoTek GFP-Booster Competitive Strengths & Weaknesses
Table 87. NanoTag Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 88. NanoTag Biotechnologies Major Business
Table 89. NanoTag Biotechnologies Anti-GFP Nanobody Product and Services
Table 90. NanoTag Biotechnologies Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. NanoTag Biotechnologies Recent Developments/Updates
Table 92. NanoTag Biotechnologies Competitive Strengths & Weaknesses
Table 93. NanoTag FluoTag-X4 anti-GFP Basic Information, Manufacturing Base and Competitors
Table 94. NanoTag FluoTag-X4 anti-GFP Major Business
Table 95. NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Product and Services
Table 96. NanoTag FluoTag-X4 anti-GFP Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. NanoTag FluoTag-X4 anti-GFP Recent Developments/Updates
Table 98. NanoTag FluoTag-X4 anti-GFP Competitive Strengths & Weaknesses
Table 99. BioLegend Basic Information, Manufacturing Base and Competitors
Table 100. BioLegend Major Business
Table 101. BioLegend Anti-GFP Nanobody Product and Services
Table 102. BioLegend Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. BioLegend Recent Developments/Updates
Table 104. BioLegend Competitive Strengths & Weaknesses
Table 105. ABclonal Agarose Beads Basic Information, Manufacturing Base and Competitors
Table 106. ABclonal Agarose Beads Major Business
Table 107. ABclonal Agarose Beads Anti-GFP Nanobody Product and Services
Table 108. ABclonal Agarose Beads Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. ABclonal Agarose Beads Recent Developments/Updates
Table 110. ABclonal Agarose Beads Competitive Strengths & Weaknesses
Table 111. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 112. Yeasen Biotechnology Major Business
Table 113. Yeasen Biotechnology Anti-GFP Nanobody Product and Services
Table 114. Yeasen Biotechnology Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Yeasen Biotechnology Recent Developments/Updates
Table 116. Yeasen Biotechnology Competitive Strengths & Weaknesses
Table 117. AntibodySystem Basic Information, Manufacturing Base and Competitors
Table 118. AntibodySystem Major Business
Table 119. AntibodySystem Anti-GFP Nanobody Product and Services
Table 120. AntibodySystem Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. AntibodySystem Recent Developments/Updates
Table 122. AntibodySystem Competitive Strengths & Weaknesses
Table 123. Antibodies.com Basic Information, Manufacturing Base and Competitors
Table 124. Antibodies.com Major Business
Table 125. Antibodies.com Anti-GFP Nanobody Product and Services
Table 126. Antibodies.com Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Antibodies.com Recent Developments/Updates
Table 128. Antibodies.com Competitive Strengths & Weaknesses
Table 129. MBL Life Science Basic Information, Manufacturing Base and Competitors
Table 130. MBL Life Science Major Business
Table 131. MBL Life Science Anti-GFP Nanobody Product and Services
Table 132. MBL Life Science Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. MBL Life Science Recent Developments/Updates
Table 134. MBL Life Science Competitive Strengths & Weaknesses
Table 135. Cosmo Bio Basic Information, Manufacturing Base and Competitors
Table 136. Cosmo Bio Major Business
Table 137. Cosmo Bio Anti-GFP Nanobody Product and Services
Table 138. Cosmo Bio Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Cosmo Bio Recent Developments/Updates
Table 140. Cosmo Bio Competitive Strengths & Weaknesses
Table 141. Bulldog Bio Basic Information, Manufacturing Base and Competitors
Table 142. Bulldog Bio Major Business
Table 143. Bulldog Bio Anti-GFP Nanobody Product and Services
Table 144. Bulldog Bio Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Bulldog Bio Recent Developments/Updates
Table 146. Bulldog Bio Competitive Strengths & Weaknesses
Table 147. System Biosciences Basic Information, Manufacturing Base and Competitors
Table 148. System Biosciences Major Business
Table 149. System Biosciences Anti-GFP Nanobody Product and Services
Table 150. System Biosciences Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. System Biosciences Recent Developments/Updates
Table 152. System Biosciences Competitive Strengths & Weaknesses
Table 153. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 154. Sino Biological Major Business
Table 155. Sino Biological Anti-GFP Nanobody Product and Services
Table 156. Sino Biological Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Sino Biological Recent Developments/Updates
Table 158. Sino Biological Competitive Strengths & Weaknesses
Table 159. CUSABIO / Wuhan Huamei Biotech Basic Information, Manufacturing Base and Competitors
Table 160. CUSABIO / Wuhan Huamei Biotech Major Business
Table 161. CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Product and Services
Table 162. CUSABIO / Wuhan Huamei Biotech Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. CUSABIO / Wuhan Huamei Biotech Recent Developments/Updates
Table 164. CUSABIO / Wuhan Huamei Biotech Competitive Strengths & Weaknesses
Table 165. MSE Supplies Basic Information, Manufacturing Base and Competitors
Table 166. MSE Supplies Major Business
Table 167. MSE Supplies Anti-GFP Nanobody Product and Services
Table 168. MSE Supplies Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. MSE Supplies Recent Developments/Updates
Table 170. MSE Supplies Competitive Strengths & Weaknesses
Table 171. KTSM Life Science Basic Information, Manufacturing Base and Competitors
Table 172. KTSM Life Science Major Business
Table 173. KTSM Life Science Anti-GFP Nanobody Product and Services
Table 174. KTSM Life Science Anti-GFP Nanobody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. KTSM Life Science Recent Developments/Updates
Table 176. KTSM Life Science Competitive Strengths & Weaknesses
Table 177. Global Key Players of Anti-GFP Nanobody Upstream (Raw Materials)
Table 178. Global Anti-GFP Nanobody Typical Customers
Table 179. Anti-GFP Nanobody Typical Distributors
LIST OF FIGURES
Figure 1. Anti-GFP Nanobody Picture
Figure 2. World Anti-GFP Nanobody Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Anti-GFP Nanobody Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 5. World Anti-GFP Nanobody Average Price (2021-2032) & (US$/Unit)
Figure 6. World Anti-GFP Nanobody Production Value Market Share by Region (2021-2032)
Figure 7. World Anti-GFP Nanobody Production Market Share by Region (2021-2032)
Figure 8. North America Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 9. Europe Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 10. China Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 11. Japan Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 12. Anti-GFP Nanobody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 15. World Anti-GFP Nanobody Consumption Market Share by Region (2021-2032)
Figure 16. United States Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 17. China Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 18. Europe Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 19. Japan Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 20. South Korea Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 22. India Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Anti-GFP Nanobody by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-GFP Nanobody Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-GFP Nanobody Markets in 2025
Figure 26. United States VS China: Anti-GFP Nanobody Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Anti-GFP Nanobody Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Anti-GFP Nanobody Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Anti-GFP Nanobody Production Market Share 2025
Figure 30. China Based Manufacturers Anti-GFP Nanobody Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Anti-GFP Nanobody Production Market Share 2025
Figure 32. World Anti-GFP Nanobody Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Anti-GFP Nanobody Production Value Market Share by Type in 2025
Figure 34. Monovalent Nanobodies
Figure 35. Bivalent Nanobodies
Figure 36. Bispecific Nanobodies
Figure 37. Multivalent Nanobodies
Figure 38. Fused Nanobodies
Figure 39. World Anti-GFP Nanobody Production Market Share by Type (2021-2032)
Figure 40. World Anti-GFP Nanobody Production Value Market Share by Type (2021-2032)
Figure 41. World Anti-GFP Nanobody Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Anti-GFP Nanobody Production Value by Reagent Format, (USD Million), 2021 & 2025 & 2032
Figure 43. World Anti-GFP Nanobody Production Value Market Share by Reagent Format in 2025
Figure 44. VHH Binding Protein
Figure 45. Affinity Gel / Resin
Figure 46. Magnetic Bead Reagent
Figure 47. Ready-to-Use IP Kit
Figure 48. World Anti-GFP Nanobody Production Market Share by Reagent Format (2021-2032)
Figure 49. World Anti-GFP Nanobody Production Value Market Share by Reagent Format (2021-2032)
Figure 50. World Anti-GFP Nanobody Average Price by Reagent Format (2021-2032) & (US$/Unit)
Figure 51. World Anti-GFP Nanobody Production Value by Conjugation Type, (USD Million), 2021 & 2025 & 2032
Figure 52. World Anti-GFP Nanobody Production Value Market Share by Conjugation Type in 2025
Figure 53. Biotin-Conjugated Type
Figure 54. Fluorophore-Conjugated Type
Figure 55. HRP-Conjugated Type
Figure 56. Bead-Coupled Type
Figure 57. World Anti-GFP Nanobody Production Market Share by Conjugation Type (2021-2032)
Figure 58. World Anti-GFP Nanobody Production Value Market Share by Conjugation Type (2021-2032)
Figure 59. World Anti-GFP Nanobody Average Price by Conjugation Type (2021-2032) & (US$/Unit)
Figure 60. World Anti-GFP Nanobody Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Anti-GFP Nanobody Production Value Market Share by Application in 2025
Figure 62. University Laboratory
Figure 63. Research Institute
Figure 64. Biotechnology Company
Figure 65. Pharmaceutical R&D Lab
Figure 66. World Anti-GFP Nanobody Production Market Share by Application (2021-2032)
Figure 67. World Anti-GFP Nanobody Production Value Market Share by Application (2021-2032)
Figure 68. World Anti-GFP Nanobody Average Price by Application (2021-2032) & (US$/Unit)
Figure 69. Anti-GFP Nanobody Industry Chain
Figure 70. Anti-GFP Nanobody Procurement Model
Figure 71. Anti-GFP Nanobody Sales Model
Figure 72. Anti-GFP Nanobody Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Anti-GFP Nanobody Picture
Figure 2. World Anti-GFP Nanobody Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Anti-GFP Nanobody Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 5. World Anti-GFP Nanobody Average Price (2021-2032) & (US$/Unit)
Figure 6. World Anti-GFP Nanobody Production Value Market Share by Region (2021-2032)
Figure 7. World Anti-GFP Nanobody Production Market Share by Region (2021-2032)
Figure 8. North America Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 9. Europe Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 10. China Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 11. Japan Anti-GFP Nanobody Production (2021-2032) & (K Units)
Figure 12. Anti-GFP Nanobody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 15. World Anti-GFP Nanobody Consumption Market Share by Region (2021-2032)
Figure 16. United States Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 17. China Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 18. Europe Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 19. Japan Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 20. South Korea Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 22. India Anti-GFP Nanobody Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Anti-GFP Nanobody by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-GFP Nanobody Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-GFP Nanobody Markets in 2025
Figure 26. United States VS China: Anti-GFP Nanobody Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Anti-GFP Nanobody Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Anti-GFP Nanobody Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Anti-GFP Nanobody Production Market Share 2025
Figure 30. China Based Manufacturers Anti-GFP Nanobody Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Anti-GFP Nanobody Production Market Share 2025
Figure 32. World Anti-GFP Nanobody Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Anti-GFP Nanobody Production Value Market Share by Type in 2025
Figure 34. Monovalent Nanobodies
Figure 35. Bivalent Nanobodies
Figure 36. Bispecific Nanobodies
Figure 37. Multivalent Nanobodies
Figure 38. Fused Nanobodies
Figure 39. World Anti-GFP Nanobody Production Market Share by Type (2021-2032)
Figure 40. World Anti-GFP Nanobody Production Value Market Share by Type (2021-2032)
Figure 41. World Anti-GFP Nanobody Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Anti-GFP Nanobody Production Value by Reagent Format, (USD Million), 2021 & 2025 & 2032
Figure 43. World Anti-GFP Nanobody Production Value Market Share by Reagent Format in 2025
Figure 44. VHH Binding Protein
Figure 45. Affinity Gel / Resin
Figure 46. Magnetic Bead Reagent
Figure 47. Ready-to-Use IP Kit
Figure 48. World Anti-GFP Nanobody Production Market Share by Reagent Format (2021-2032)
Figure 49. World Anti-GFP Nanobody Production Value Market Share by Reagent Format (2021-2032)
Figure 50. World Anti-GFP Nanobody Average Price by Reagent Format (2021-2032) & (US$/Unit)
Figure 51. World Anti-GFP Nanobody Production Value by Conjugation Type, (USD Million), 2021 & 2025 & 2032
Figure 52. World Anti-GFP Nanobody Production Value Market Share by Conjugation Type in 2025
Figure 53. Biotin-Conjugated Type
Figure 54. Fluorophore-Conjugated Type
Figure 55. HRP-Conjugated Type
Figure 56. Bead-Coupled Type
Figure 57. World Anti-GFP Nanobody Production Market Share by Conjugation Type (2021-2032)
Figure 58. World Anti-GFP Nanobody Production Value Market Share by Conjugation Type (2021-2032)
Figure 59. World Anti-GFP Nanobody Average Price by Conjugation Type (2021-2032) & (US$/Unit)
Figure 60. World Anti-GFP Nanobody Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Anti-GFP Nanobody Production Value Market Share by Application in 2025
Figure 62. University Laboratory
Figure 63. Research Institute
Figure 64. Biotechnology Company
Figure 65. Pharmaceutical R&D Lab
Figure 66. World Anti-GFP Nanobody Production Market Share by Application (2021-2032)
Figure 67. World Anti-GFP Nanobody Production Value Market Share by Application (2021-2032)
Figure 68. World Anti-GFP Nanobody Average Price by Application (2021-2032) & (US$/Unit)
Figure 69. Anti-GFP Nanobody Industry Chain
Figure 70. Anti-GFP Nanobody Procurement Model
Figure 71. Anti-GFP Nanobody Sales Model
Figure 72. Anti-GFP Nanobody Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
